Medicare drug plans can now cover Eli Lilly & Co.’s obesity drug Zepbound as a treatment for obstructive sleep apnea, news that’s expected to prove a big boost for the drug company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback